Sygnature Discovery North America

Sygnature Discovery North America

Research-Services

Montreal, Quebec
Canada
Company Tagline

Enabling Success

Industry Category
Research-Services
Company Description

Sygnature Discovery North America is a leading research services provider dedicated to enabling success in the pharmaceutical and biotechnology industries. With a focus on innovation and scientific excellence, Sygnature Discovery North America offers a comprehensive suite of services designed to accelerate drug discovery and development processes. Located at Primary: 2350 Rue Cohen Suite 201 Montreal, Quebec H4R 2N6, CA; 480 Rue Perreault Lévis, Quebec G6W 7V6, CA; 275 Boulevard Armand-Frappier Laval, Quebec H7V 4A7, CA; 4800 Rue Dobrin Montreal, Quebec H4R 2P8, CA; 7171 Rue Frederick-Banting Montreal, Quebec H4S 1Z9, CA, Sygnature Discovery North America is strategically positioned to serve its global partners.

Sygnature Discovery North America leverages cutting-edge technologies and a team of highly skilled scientists to deliver tailored solutions that meet the unique needs of each client. The company’s expertise spans a wide range of therapeutic areas, ensuring comprehensive support from initial target identification to preclinical development. Sygnature Discovery North America is committed to driving scientific breakthroughs and improving patient outcomes through collaborative partnerships and innovative research.

Through its unwavering commitment to quality, innovation, and client satisfaction, Sygnature Discovery North America continues to be a trusted partner for organizations seeking to advance their drug discovery programs. We invite the management team at Sygnature Discovery North America to enhance your company’s visibility and attract new opportunities by creating a customized and exclusive company showcase and product listing on our platform.

Sygnature Discovery North America est un fournisseur de premier plan de services de recherche dédié à favoriser le succès dans les industries pharmaceutiques et biotechnologiques. En mettant l'accent sur l'innovation et l'excellence scientifique, Sygnature Discovery North America offre une suite complète de services conçus pour accélérer les processus de découverte et de développement de médicaments. Située à Primary: 2350 Rue Cohen Suite 201 Montréal, Québec H4R 2N6, CA; 480 Rue Perreault Lévis, Québec G6W 7V6, CA; 275 Boulevard Armand-Frappier Laval, Québec H7V 4A7, CA; 4800 Rue Dobrin Montréal, Québec H4R 2P8, CA; 7171 Rue Frederick-Banting Montréal, Québec H4S 1Z9, CA, Sygnature Discovery North America est stratégiquement positionnée pour servir ses partenaires mondiaux.

Sygnature Discovery North America exploite des technologies de pointe et une équipe de scientifiques hautement qualifiés pour fournir des solutions sur mesure qui répondent aux besoins uniques de chaque client. L'expertise de l'entreprise couvre un large éventail de domaines thérapeutiques, garantissant un soutien complet depuis l'identification initiale de la cible jusqu'au développement préclinique. Sygnature Discovery North America s'engage à favoriser les avancées scientifiques et à améliorer les résultats pour les patients grâce à des partenariats collaboratifs et à une recherche innovante.

Grâce à son engagement indéfectible envers la qualité, l'innovation et la satisfaction de ses clients, Sygnature Discovery North America continue d'être un partenaire de confiance pour les organisations cherchant à faire progresser leurs programmes de découverte de médicaments. Nous invitons l'équipe de direction de Sygnature Discovery North America à améliorer la visibilité de votre entreprise et à attirer de nouvelles opportunités en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.

Key Personnel / Employees
Kathy McCusker René Coulombe Nicolas Morin Sanjay Patel

Compare Companies Side by Side

Compare Sygnature Discovery North America with 3 companies in Research-Services

4 Companies
Comparison Field
Sygnature Discovery North America
Sygnature Discovery North...
Main Company
Th
The Herbert Wertheim...
View Profile
CrystalsFirst
CrystalsFirst
View Profile
Founded Year
2004 2018 2016
Company Size
501-1,000 11-50 11-50
City
Montreal, Quebec Hamburg, HH Abingdon, Oxfordshire, England
Country
Canada Germany
Skills & Keywords Comparing with main company
39 Total Skills
Drug Discovery Preclinical Development Research Services Pharmaceutical Industry Biotechnology Medicinal Chemistry In vivo pharmacology medicinal chemistry drug discovery chemical synthesis assay development CRO chemistry hit finding hit to lead lead optimisation computational chemistry process chemistry biology pharmacology structural biology small molecule compound screening biochemistry lead optimization oncolocy metabolic disease inflammation pain neuroscience DMPK ADME in vivo crystallography cell biology infectious diseases protein production virtual screening target identification
5 Total 5 Unique
Unique Skills:
chemical biology energy catalysis high-throughput screening metabolism virology
7 Total 7 Unique
Unique Skills:
FBDD FBLD fragment-based drug discovery fragment-based lead discovery generative AI lead discovery +1
16 Total 16 Unique
Unique Skills:
AI antibodies automation biophysics Biotech consultation +10
4
Total Companies
2004
Oldest Founded
2
Countries
67
Unique Skills

Similar Companies

Other organizations in the same industry

MILAN Testing Laboratory
Research-Services

Somos un laboratorio bromatológico orientado al análisis de alimentos animal, humano y otras matrice...

Brandenburg Labs GmbH
Research-Services

audio expertise

Ilmenau, Thüringen
Germany
SEQUOIA Horizon Europe project
Research-Services

Sensing using quantum OCT with AI

Forschungscampus Digital Photonic Production DPP
Research-Services

From Bits to Photons to Atoms

Aachen, Nordrhein-We...
Germany

Alternative Company Names

This company is also known as

Sygnature Discovery North America सिग्नेचर डिस्कवरी नॉर्थ अमेरिका সিগনেচার ডিসকভারি নর্থ আমেরিকা Сигнатурное открытие Северной Америки